APGE
APGE
NASDAQ · Biotechnology

Apogee Therapeutics Inc

$83.03
+1.22 (+1.49%)
As of May 9, 1:20 AM ET ·
Analyst Consensus
Strong Buy
23
Analysts
High
Coverage
Buy 19 83%
Hold 4 17%
Sell 0 0%
Price Target
Analyst Price Target +22.3% upside
Low Target $78.76
Average Target $101.57
High Target $153.22
Current Price $83.03
Current
$83.03
Target
$101.57
$78.76 $101.57 avg $153.22
Scenario Analysis
Bear Case
$78.76
-5.1%
Low target
Base Case
$101.57
+22.3%
Avg target
Bull Case
$153.22
+84.5%
High target
Risk/Reward
16.4x
Highly favorable
Price in Context
52-Week High
$95.32
-12.9% from high
52-Week Low
$34.34
+141.8% from low
50-Day SMA
$73.88
+12.4% vs SMA
200-Day SMA
$52.13
+59.3% vs SMA
RSI (14)
48.1
Neutral
Target vs 52W High
$101.57
+6.6% vs high
Next Earnings Report
May 11, 2026
Today
EPS Est: $-1.12
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
Strong Buy 28 96% $143.40 +41.5%